State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 17, Issue 1-2, 2016, Pages 128-134

  Wagner, Laurie ^a   Rechtman, Lindsay ^a   Jordan, Heather ^a   Ritsick, Maggie ^a   Sanchez, Marchelle ^b   Sorenson, Eric ^c   Kaye, Wendy ^a  

^a McKing Consulting Corp   (United States)

^b AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

^c MAYO CLINIC   (United States)

Author keywords

ALS surveillance; Amyotrophic lateral sclerosis (ALS); epidemiology; incidence; prevalence

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASIAN; COMPARATIVE STUDY; DEMENTIA; DEMOGRAPHY; DISEASE SURVEILLANCE; ETHNIC DIFFERENCE; ETHNIC OR RACIAL ASPECTS; FEMALE; GENDER; HUMAN; ICD-10; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MIDDLE AGED; PRIORITY JOURNAL; RACIAL DISTRIBUTION; UNITED STATES; URBAN AREA; ANCESTRY GROUP; CITY; ETHNOLOGY; HEALTH SURVEY; PROCEDURES; REGISTER; SEX RATIO; STATISTICS AND NUMERICAL DATA; URBAN POPULATION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; CITIES; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; REGISTRIES; SEX DISTRIBUTION; UNITED STATES; URBAN POPULATION; YOUNG ADULT;

EID: 84955643143     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2015.1074699     Document Type: Article

References (37)

1. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the common neurologic disorders? Neurology. 2007; 68: 326-37.
2. Chio A, Logrosino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013; 41: 118-30.
3. Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007; 68: 1002-7.
4. Gundogdu B, Al-Lahham T, Kadlubar F, Spencer H, Rudnicki SA. Racial differences in motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener. 2014; 15: 114-8.
5. Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population based mortality study. Neurology. 2009; 72: 1640-5.
6. Wagner L, Archer NP, Williamson D, Henry JP, Schiffer R, Jackson CE,. Prevalence of amyotrophic lateral sclerosis in Texas, 1998-2003. Tex Med. 2012; 108: e1.
7. Turabelidze G, Zhu B, Schootman M, Malone J, Horowitz S, Weidinger J, et al. An epidemiological investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998-2002. Neurotoxicology. 2008; 29: 81-6.
8. Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ,. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925-1998. Neurology. 2002; 59: 280-2.
9. Mehta P, Antao V, Kaye W, Sanchez M, Williamson D, Bryan L, et al. Prevalence of amyotrophic lateral sclerosis-United States, 2010-2011. MMWR Surveill Summ. 2014; 63 (Suppl 7): 1-14.
10. Antao VC, Horton DK. The National Amyotrophic Lateral Sclerosis (ALS) Registry. J Environ Health. 2012; 75: 28-30.
11. Kaye WE, Sanchez M, Wu J. Feasibility of creating a National ALS Registry using administrative data in the United States. Amyotroph Lateral Scler Frontotemporal Degener. 2014; 15: 433-9.
12. Brooks BR, Miller RG, Swash M, Munsat TL.; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: Revised criteria for the diagnosis of Amyotrophic Lateral Sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1: 293-9.
13. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10). Geneva: World Health Organization 1992.
14. U.S. Census Population estimates. [Online]. 2014. Available from: URL: http://www.census.gov/popest/data/national/totals/2013/index.html. Accessed on October 15, 2014.
15. Microsoft Excel [computer program]. Redmond, Washington: Microsoft; 2010.
16. IBM SPSS Statistics for Windows., Version 19.0 [computer program]. Armonk, NY: IBM Corp; 2010.
17. Gardner MJ, Altman DG. Confidence intervals rather than p-values: estimation rather than hypothesis testing. Br Med J (Clin Res Ed). 1986; 292: 746-50.
18. Wijesekera LC, Leigh PN,. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009; 4: 3.
19. Louwerse ES, Visser CE, Bossuyt PM, Weverling GJ., The Netherlands ALS Consortium. Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. J Neurol Sci. 1997; 152 (Suppl 1): S10-7.
20. Logrosino G, Traynor B, Hardiman O, Chio A, Mitchell D, Swingler R, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010; 81: 385-90.
21. McGuire V, Longsreth WT, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington State. Neurology. 1996; 47: 571-3.
22. Ragonese P, Cellura E, Aridon P, D'amelio M, Spartaro R, Taiello AC, et al. Incidence of amyotrophic lateral sclerosis in Sicily: a population based study. Amyotroph Lateral Scler. 2012; 13: 284-7.
23. Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology. 2008; 71: 1889-95.
24. Jordan H, Fagliano J, Rechtman L, Lefkowitz D, Kaye W. Effects of Demographic Factors on Survival Time after a Diagnosis of Amyotrophic Lateral Sclerosis. Neuroepidemiology. 2015; 44: 114-20.
25. Cellura E, Spataro R, Taiello A, La Bella V. Factors affecting the diagnostic delay in amyotrophic lateral sclerosis. Clinical Neurology and Neurosurgery. 2012; 114: 550-4.
26. Khishchenko N, Allen K, Coffman C, Kasaeskis E, Lindquist J, Morgenlander J, et al. Time to diagnosis in the National Registry of Veterans with Amyotrophic Lateral Sclerosis. Amyotroph Lateral Scler. 2010; 11: 125-32.
27. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman OM. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population based study. Arch Neurol. 2000; 57: 1171-6.
28. OToole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008; 79: 30-2.
29. Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-Analysis. J Neurol Neurosurg Psychiatry. 2011; 82: 623-7.
30. Gibson SB, Figueroa KP, Bromberg MB, Pulst SM, Cannon-Albright L. Familial clustering of ALS in a population based resource. Neurology. 2014; 82: 17-22.
31. Strong M, Grace G, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein L, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioral syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009; 10: 131-46.
32. Gordon P, Delgadillo D, Piquad A, Bruneteau G, Pradat P, Salachas F, et al. The range and clinical impact of cognitive impairment in French patients with ALS: a cross-sectional study of neuropsychological test performance. Amyotroph Lateral Scler. 2011; 12: 372-8.
33. Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2012; 83: 102-8.
34. Ringholz G, Appel S, Bradshaw M, Cooke N, Mosnik, D, Schulz P. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005; 65: 586-90.
35. Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, et al. Cognitive correlates in amyotrophic lateral sclerosis: a population based study in Italy. J Neurol Neurosurg Psychiatry. 2015; 86: 168-73.
36. Mitsumoto H, Factor-Litvak P, Andrews H, Goetz RR, Andrews L, Rabkin JG, et al.; ALS COSMOS Study Group. ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics. Amyotroph Lateral Scler Frontotemporal Degener. 2014; 15: 192-203.
37. Belsh JM. Diagnostic challenges in ALS. Neurology. 1999; 53 (Suppl 5): S26-30; discussion S35-6.